Literature DB >> 21254793

Low efficacy of transdermal sumatriptan in migraine.

Peer Tfelt-Hansen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254793     DOI: 10.2165/11587750-000000000-00000

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  5 in total

1.  Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.

Authors:  M D Ferrari; P J Goadsby; K I Roon; R B Lipton
Journal:  Cephalalgia       Date:  2002-10       Impact factor: 6.292

Review 2.  Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.

Authors:  Alan M Rapoport; Fred Freitag; Starr H Pearlman
Journal:  CNS Drugs       Date:  2010-11       Impact factor: 5.749

3.  What do patients with migraine want from acute migraine treatment?

Authors:  Richard B Lipton; Sandra W Hamelsky; Jeffrey M Dayno
Journal:  Headache       Date:  2002-01       Impact factor: 5.887

4.  Zelrix: a novel transdermal formulation of sumatriptan.

Authors:  Mark Pierce; Thomas Marbury; Carol O'Neill; Steven Siegel; Wei Du; Terri Sebree
Journal:  Headache       Date:  2009-04-27       Impact factor: 5.887

Review 5.  Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment.

Authors:  Peer Tfelt-Hansen
Journal:  J Headache Pain       Date:  2007-10-23       Impact factor: 7.277

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.